Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours Β· Estimated delivery Oct 9 - Oct 14
That original function is still active, which means it can address two goals within the same protocol
BPC-157 is a superior joint pain solution because it addresses the cause of the pain rather than just covering up the symptoms
Cellular Senescence Research: the compound is studied in longevity and cellular senescence models where NAD+ decline is a characterized feature
That triple mechanism is what produced the headline-grabbing results from the Phase 2 NEJM trial, where the 12 mg dose group achieved an average 24.2% body weight reduction over 48 weeks
Blood Flow and Angiogenesis : Preclinical findings indicate stimulation of new blood vessel formation, which may improve oxygen and nutrient delivery to damaged tissues
/assets/images/provider/photos/2632869.jpg)
